RMED Ra Medical Systems, Inc.

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

$1.86  +0.04 (1.92%)
As of 12/07/2021 12:00:08 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  09/27/2018
Outstanding shares:  7,029,765
Average volume:  235,377
Market cap:   $12,196,642
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74933X104
ISIN:        US74933X1046
Sedol:      BF12X88
Valuation   (See tab for details)
PE ratio:   -0.47
PB ratio:   0.59
PS ratio:   3.65
Return on equity:   -126.35%
Net income %:   -813.96%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy